Latest News- Antibody Market: Monoclonal antibodies is expected to lead the Type segment during 2025-2029

The Antibody Market is being driven by Technological advancements and innovation in antibody engineering

The Antibody Market is expected to grow at a CAGR of 8.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 8958 million. The global antibody market is witnessing a significant shift towards next-generation engineered constructs, such as antibody drug conjugates (ADCs) and bispecific antibodies, from conventional monoclonal antibodies. This trend signifies a transformative development in therapeutic approaches, aimed at overcoming treatment resistance, amplifying efficacy, and improving safety profiles in intricate diseases, particularly cancer. ADCs epitomize this innovation, combining a highly targeted antibody with a cytotoxic agent to create a biological missile that delivers its payload directly to cancer cells. This targeted approach minimizes systemic exposure and associated toxicity, enabling the utilization of potent anti-cancer agents that would otherwise be infeasible due to their systemic toxicity. 

Get more information on Antibody Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Monoclonal antibodies
  • Polyclonal antibodies
  • Others
• Therapeutic Area
  • Oncology
  • Autoimmune diseases
  • Infectious diseases
  • Cardiovascular diseases
  • Others
• Application
  • Therapeutic
  • Diagnostic
  • Research
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Technological advancements and innovation in antibody engineering
• Expanding therapeutic applications and addressing high unmet medical needs
• Rising prevalence of chronic diseases and a favorable regulatory environment

However, the market also witnesses some limitations, which are as follows:

• Intense pricing pressure and payer scrutiny
• High cost, length, and complexity of research, development, and manufacturing
• Growing competition from biosimilars and alternative therapeutic modalities

Benefits of Buying Global Antibody Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Antibody Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Antibody Market encompasses technologies and services related to the characterization and production of antibodies. Key areas include determining immunoglobulin classes through antibody isotyping, assessing epitope mapping and antibody titer. Serum antibody levels are measured for cross-reactivity testing and specificity evaluation. Affinity maturation, antigen presentation, and immune response evaluation are crucial for b and T cell activation. Complement activation, secondary antibody selection, and labeling methods like immunofluorescence microscopy and confocal microscopy are used for analysis. Techniques such as antibody microarray, proteomic analysis, peptide mapping, mass spectrometry, protein sequencing, glycosylation analysis, antibody purification scale-up, antibody formulation, stability indicators, quality control testing, and regulatory compliance are integral to biopharmaceutical manufacturing.

Market Research Overview

In the dynamic landscape of the global pharmaceuticals market, the sub-sector of antibody production and related technologies holds significant potential for growth. This sector encompasses companies specializing in monoclonal antibody production and polyclonal antibody purification, as well as the development of immunoglobulin structures and antibody-drug conjugates. The market's expansion is driven by several key factors, including the increasing global population aging, with predictions that by 2050, approximately one-quarter of the US and European populations will be over 60 years old. This demographic shift will necessitate a rise in demand for healthcare solutions, including antibody-based therapies. Technavio, a leading market research firm, projects the global healthcare market to grow, driven by the combined revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. This trend is expected to significantly impact the antibody production sector, as the aging population's increased healthcare needs will fuel demand for advanced antibody-based therapies.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/